8 Best Small Cap Pharma Stocks to Buy Right Now

Page 2 of 2

6. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Number of Hedge Fund Holders: 22  

Market Capitalization: $807.78 million 

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is among the best pharmaceutical stocks on this list.

TheFly reported on May 13 that Wells Fargo downgraded AMPH to Equal Weight from Overweight, with the price objective reduced to $19 from $30 in a revised research note. The updated view reflects greater uncertainty around the company’s revenue trajectory for 2026 and 2027, along with reduced confidence in its ability to meet its 2026 outlook. The note also highlighted concerns related to AMP-004, particularly the risk tied to its potential to achieve interchangeability status, which could influence longer-term competitive positioning and growth expectations.

On May 7, Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) reported first-quarter 2026 results for the period ended March 31, 2026, with revenue of $171.2 million versus consensus estimates of $173.4 million. The company highlighted continued progress in strengthening its commercial base and core operations during the quarter. Key developments included the approval and launch of Ipratropium Bromide HFA, alongside broader pipeline advancement supporting long-term strategic growth.

Management also pointed to an expanded product portfolio through an exclusive licensing agreement for a fully synthetic corticotropin compound. The company emphasized ongoing investment in proprietary pipeline assets and internal capabilities aimed at sustaining long-term expansion and operational resilience.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is a biopharmaceutical company that develops, manufactures, and markets complex generic and proprietary injectable, inhalation, and intranasal drugs, mainly serving hospital and emergency care markets.

While we acknowledge the potential of AMPH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AMPH and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Best Small Cap Pharma Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.

Page 2 of 2
1281292 - 11759070 - 1